Meet us at BioEquity Europe 2025 in Bruges (BE)

    Posted on : |

    Dendrogenix CEO, CSO and CDO will attend to BioEquity Europe 2025 | May 12–14, 2025 | Bruges, Belgium. Celebrating its 25th year, BioEquity Europe is the destination event for biopharma decision-makers to network, partner and debate critical issues facing the biotech industry.

    Tuesday October 22nd, 2024
    Next
    DENDROGENIX S.A.

    Founded in 2018, Dendrogenix develop first-in-class molecules, Dendrogenins, to address high unmet medical needs in hearing loss and neurology.

    © 2024 Dendrogenix